Latest Trials Latest NewsFAQ

VIRGINIA COMMONWEALTH UNIVERSITY

🇺🇸United States

Country: 🇺🇸United States

Ownership: Private

Established: 1838-01-01

Employees: 10K

Market Cap: -

Website: http://www.vcu.edu

Clinical Trials

Postoperative Pain Control After Periarticular Injection During Total Knee Arthroplasty

Phase 4

Terminated

Conditions: Osteoarthritis, Knee

Interventions: Drug: 0.9% sodium chloride
Drug: Ropivacaine
Drug: Ketorolac
Drug: Clonidine
Drug: Epinephrine

First Posted Date: 2015-10-07

Last Posted Date: 2022-03-04

Lead Sponsor: Virginia Commonwealth University

Target Recruit Count: 64

Registration Number: NCT02570503

Locations: 🇺🇸
Virginia Commonwealth University, Richmond, Virginia, United States

MRI-Based Active Surveillance to Avoid the Risks of Serial Biopsies in Men With Low-Risk Prostate Ca

Not Applicable

Terminated

Conditions: Prostate Cancer
Multiparametric MRI
Prostate Adenocarcinoma
Gleason's Score 6

Interventions: Procedure: TRUS-guided biopsy
Procedure: mpMRI with targeted biopsy

First Posted Date: 2015-09-30

Last Posted Date: 2017-10-19

Lead Sponsor: Virginia Commonwealth University

Target Recruit Count: 28

Registration Number: NCT02564549

Locations: 🇺🇸
Hunter Holmes Mcguire Veteran Affairs Medical Center, Richmond, Virginia, United States

Drug Interaction and Self Administration Studies of Compounds for Cocaine Use Disorder

Phase 1

Completed

Conditions: Cocaine Use Disorder

Interventions: Drug: Lorcaserin
Drug: Cocaine Intravenous (IV)
Drug: Placebo comparator

First Posted Date: 2015-09-02

Last Posted Date: 2020-05-12

Lead Sponsor: Virginia Commonwealth University

Target Recruit Count: 29

Registration Number: NCT02537873

Locations: 🇺🇸
Virginia Commonwealth University, Institute for Drug and Alcohol Studies, Richmond, Virginia, United States

Patient Buddy App for the Prevention of Avoidable Readmission in Cirrhosis

Completed

Conditions: Cirrhosis

First Posted Date: 2015-08-28

Last Posted Date: 2018-06-12

Lead Sponsor: Virginia Commonwealth University

Target Recruit Count: 38

Registration Number: NCT02534805

Locations: 🇺🇸
Virginia Commonwealth University, Richmond, Virginia, United States

Hypofractionated Regional Nodal Irradiation Clinical Trial for Women With Breast Cancer

Not Applicable

Active, not recruiting

Conditions: Invasive Breast Carcinoma
Lobular Breast Carcinoma In Situ
Breast Cancer
Node-positive Breast Cancer
Breast Adenocarcinoma

Interventions: Radiation: External Beam Radiation Therapy
Other: Questionnaire Administration
Other: Laboratory Biomarker Analysis

First Posted Date: 2015-08-04

Last Posted Date: 2024-04-23

Lead Sponsor: Virginia Commonwealth University

Target Recruit Count: 137

Registration Number: NCT02515110

Locations: 🇺🇸
VCU Community Memorial Healthcenter, South Hill, Virginia, United States
🇺🇸
Virginia Commonwealth University/Massey Cancer Center, Richmond, Virginia, United States

Understanding the Value of Community Vital Signs in Primary Care

Completed

Conditions: Colon Cancer
Breast Cancer
Prostate Cancer
Cardiovascular Disease
Cervical Cancer

Interventions: Other: Community vital signs

First Posted Date: 2015-07-31

Last Posted Date: 2018-02-28

Lead Sponsor: Virginia Commonwealth University

Target Recruit Count: 120

Registration Number: NCT02512835

Locations: 🇺🇸
Virginia Ambulatory Care Outcomes Research Network, Richmond, Virginia, United States
🇺🇸
Fairfax Family Practice Centers, Fairfax, Virginia, United States

The Effect of Electronic Cigarette (ECIG) Liquid Vehicles on ECIG Acute Effects

Phase 1

Completed

Conditions: Nicotine Exposure
Nicotine Withdrawal Suppression

Interventions: Other: ECIG liquid vehicles

First Posted Date: 2015-07-16

Last Posted Date: 2018-05-07

Lead Sponsor: Virginia Commonwealth University

Target Recruit Count: 41

Registration Number: NCT02500615

Locations: 🇺🇸
Clinical Behavioral Pharmacology Laboratory, Richmond, Virginia, United States

Study of Regorafenib and Sildenafil for Advanced Solid Tumors

Phase 1

Completed

Conditions: Solid Tumor

Interventions: Drug: Regorafenib
Drug: Sildenafil Citrate

First Posted Date: 2015-06-09

Last Posted Date: 2020-02-20

Lead Sponsor: Virginia Commonwealth University

Target Recruit Count: 32

Registration Number: NCT02466802

Locations: 🇺🇸
Virginia Commonwealth University/Massey Cancer Center, Richmond, Virginia, United States

Pilot Study of Oral Probiotic Bacteria Supplementation to Reduce Chronic Immune Activation in HIV-infected Malian Women

Not Applicable

Completed

Conditions: HIV

Interventions: Other: VSL#3® probiotic

First Posted Date: 2015-05-19

Last Posted Date: 2017-06-14

Lead Sponsor: Virginia Commonwealth University

Target Recruit Count: 23

Registration Number: NCT02448238

Locations: 🇲🇱
Nianankoro Fomba Hospital, Ségou, Ségou Region, Mali

CBT-I Intervention for Insomnia in Newly Diagnosed Cancer Patients

Not Applicable

Terminated

Conditions: Cancer
Chronic Insomnia

Interventions: Behavioral: cognitive behavioral therapy for insomnia (CBTI)
Behavioral: Waitlist control condition

First Posted Date: 2015-04-07

Last Posted Date: 2016-02-10

Lead Sponsor: Virginia Commonwealth University

Target Recruit Count: 29

Registration Number: NCT02410564

Locations: 🇺🇸
Virginia Commonwealth University/Massey Cancer Center, Richmond, Virginia, United States

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy